Marc Vogel

Dr. Marc Vogel

Department of Substance Use and Addictive Disorders, Psychiatric University Clinics Basel, Basel, Switzerland

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2016 in Substance Abuse and Rehabilitation
Verified
Journal Article
Open access
PDF file
MVMarc Vogel
Marc Vogel
RHRobert Hämmig
Robert Hämmig
AKAntje Kemter
Antje Kemter
JSJohannes Strasser
Johannes Strasser
UBUlrich von Bardeleben
Ulrich von Bardeleben
KDKenneth M Dürsteler
Kenneth M Dürsteler
Background: Buprenorphine is a partial µ-opioid receptor agonist used for maintenance treatment of opioid dependence. Because of the partial agonism and high receptor affinity, it may precipitate withdrawal symptoms during induction in persons on full µ-opioid receptor agonists. Therefore, current guidelines and drug labels recommend leaving a sufficient time period since the last full agonist use, waiting for clear and objective withdrawal symptoms, and reducing pre-existing full agonist therapies before administering buprenorphine. However, even with these precautions, for many patients the induction of buprenorphine is a difficult experience, due to withdrawal symptoms. Furthermore, tapering of the full agonist bears the risk of relapse to illicit opioid use. Cases: We present two cases of successful initiation of buprenorphine treatment with the ­Bernese method, ie, gradual induction overlapping with full agonist use. The first patient began buprenorphine with overlapping street heroin use after repeatedly experiencing relapse, withdrawal, and trauma reactivation symptoms during conventional induction. The second patient was maintained on high doses of diacetylmorphine (ie, pharmaceutical heroin) and methadone during induction. Both patients tolerated the induction procedure well and reported only mild withdrawal symptoms. Discussion: Overlapping induction of buprenorphine maintenance treatment with full µ-opioid receptor agonist use is feasible and may be associated with better tolerability and acceptability in some patients compared to the conventional method of induction.

27 January 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KMKai MacDonald
Kai MacDonald
MTMichael L. Thomas
Michael L. Thomas
ASAndres F. Sciolla
Andres F. Sciolla
BSBeacher Schneider
Beacher Schneider
KPKatherine Pappas
Katherine Pappas
KWKatja Wingenfeld
Katja Wingenfeld
Childhood maltreatment has diverse, lifelong impact on morbidity and mortality. The Childhood Trauma Questionnaire (CTQ) is one of the most commonly used scales to assess and quantify these experiences and their impact. Curiously, despite very widespread use of the CTQ, scores on its Minimization-Denial (MD) subscale—originally designed to assess a positive response bias—are rarely reported. Hence, little is known about this measure. If response biases are either common or consequential, current practices of ignoring the MD scale deserve revision. Therewith, we designed a study to investigate 3 aspects of minimization, as defined by the CTQ’s MD scale: 1) its prevalence; 2) its latent structure; and finally 3) whether minimization moderates the CTQ’s discriminative validity in terms of distinguishing between psychiatric patients and community volunteers. Archival, item-level CTQ data from 24 multinational samples were combined for a total of 19,652 participants. Analyses indicated: 1) minimization is common; 2) minimization functions as a continuous construct; and 3) high MD scores attenuate the ability of the CTQ to distinguish between psychiatric patients and community volunteers. Overall, results suggest that a minimizing response bias—as detected by the MD subscale—has a small but significant moderating effect on the CTQ’s discriminative validity. Results also may suggest that some prior analyses of maltreatment rates or the effects of early maltreatment that have used the CTQ may have underestimated its incidence and impact. We caution researchers and clinicians about the widespread practice of using the CTQ without the MD or collecting MD data but failing to assess and control for its effects on outcomes or dependent variables.

3 December 2014 in European Archives of Psychiatry and Clinical Neuroscience
Verified
Journal Article
Closed access
PDF file
CSChristian L. Seifert
Christian L. Seifert
SMStefano Magon
Stefano Magon
TSTill Sprenger
Till Sprenger
ULUndine E. Lang
Undine E. Lang
CHChristian G. Huber
Christian G. Huber
MWMarc Walter
Marc Walter

1 October 2013 in Addictive Behaviors
Verified
Journal Article
Closed access
MVMarc Vogel
Marc Vogel
BKBina Knöpfli
Bina Knöpfli
OSOtto Schmid
Otto Schmid
MPMari Prica
Mari Prica
JSJohannes Strasser
Johannes Strasser
KDKenneth M. Dürsteler-MacFarland
Kenneth M. Dürsteler-MacFarland

1 July 2014 in Journal of Psychiatric Research
Verified
Journal Article
Closed access
HJHermann-Alexander Jungfer
Hermann-Alexander Jungfer
ASAndres Schneeberger
Andres Schneeberger
SBStefan Borgwardt
Stefan Borgwardt
MWMarc Walter
Marc Walter
MVMarc Vogel
Marc Vogel
CHChristian G. Huber
Christian G. Huber

1 May 2017 in Journal of Substance Abuse Treatment
Verified
Journal Article
Open access
FCFlora Colledge
Flora Colledge
MVMarc Vogel
Marc Vogel
KDKenneth Dürsteler-Macfarland
Kenneth Dürsteler-Macfarland
JSJonas Strom
Jonas Strom
SSSusanne Schoen
Susanne Schoen
MGMarkus Gerber
Markus Gerber
Although the potential of exercise as an adjunct treatment for substance dependence is persuasive in theory, few controlled trials have assessed its effectiveness. Existing research has also largely focused on individuals aiming towards, or having already achieved, abstinence. This study employed a randomized design in a pilot trial to assess the feasibility, acceptance, and effects of an exercise intervention for individuals receiving outpatient heroin-assisted treatment. 50 individuals receiving heroin-assisted treatment at a clinic in Switzerland were invited to take part in the trial. Participants were randomized to 12weeks of exercise twice per week, or a corresponding duration of non-exercise group activities in a comparison condition. Data on attendance, compliance, and numerous psychological and physiological parameters were gathered. 24 individuals were willing to take part in the study. 92.3% of the exercise condition (n=13) were compliant or semi-compliant with the protocol; by contrast, only 54.6% of participants in the comparison condition (n=11) were compliant or semi-compliant (χ2=7.049; p=0.029). Participants in the exercise condition significantly increased the number of minutes spent exercising at a high intensity level (F(2,44)=3.794; p=0.046; η2=0.159). No other significant interaction effects were observed. An exercise intervention is a feasible and accepted supplementary therapy to heroin-assisted treatment. Participation rates were high, particularly given the outpatient setting. No evidence regarding the potential mechanisms of exercise as a therapy modality could be identified. Patients in heroin-assisted treatment may require a longer-term exercise programme, specifically targeting particular health parameters, before measurable improvements can be observed.